TRIMETH/SULFA Drug Patent Profile
✉ Email this page to a colleague
Which patents cover Trimeth/sulfa, and what generic alternatives are available?
Trimeth/sulfa is a drug marketed by Alpharma Us Pharms and Naska and is included in three NDAs.
The generic ingredient in TRIMETH/SULFA is sulfamethoxazole; trimethoprim. There are twenty-seven drug master file entries for this compound. Forty-nine suppliers are listed for this compound. Additional details are available on the sulfamethoxazole; trimethoprim profile page.
DrugPatentWatch® Litigation and Generic Entry Outlook for Trimeth/sulfa
A generic version of TRIMETH/SULFA was approved as sulfamethoxazole; trimethoprim by SUN PHARM INDUSTRIES on August 25th, 1986.
AI Research Assistant
Questions you can ask:
- What is the 5 year forecast for TRIMETH/SULFA?
- What are the global sales for TRIMETH/SULFA?
- What is Average Wholesale Price for TRIMETH/SULFA?
Summary for TRIMETH/SULFA
| US Patents: | 0 |
| Applicants: | 2 |
| NDAs: | 3 |
| Raw Ingredient (Bulk) Api Vendors: | 162 |
| DailyMed Link: | TRIMETH/SULFA at DailyMed |
US Patents and Regulatory Information for TRIMETH/SULFA
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Alpharma Us Pharms | TRIMETH/SULFA | sulfamethoxazole; trimethoprim | SUSPENSION;ORAL | 072289-001 | May 23, 1988 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
| Alpharma Us Pharms | TRIMETH/SULFA | sulfamethoxazole; trimethoprim | SUSPENSION;ORAL | 072398-001 | May 23, 1988 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
| Naska | TRIMETH/SULFA | sulfamethoxazole; trimethoprim | SUSPENSION;ORAL | 072399-001 | May 23, 1988 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
